LobbyingTiger Biosciences lobbying by quarter
Tiger Biosciences's latest lobbying report covers Q2 2026, at $450K. The four quarters Q4 2025–Q3 2026 total $1.1M. Its first report covers Q1 2024; the issues it reports most are Medicare/Medicaid and Medical/Disease Research/Clinical Labs.
Tiger Biosciences
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $1.2M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2024 | $50K | 1 |
| Q2 2024 | $80K | 1 |
| Q3 2024 | $80K | 1 |
| Q4 2024 | $80K | 1 |
| Q1 2025 | $80K | 1 |
| Q2 2025 | $80K | 1 |
| Q3 2025 | $80K | 1 |
| Q4 2025 | $200K | 1 |
| Q1 2026 | $500K | 1 |
| Q2 2026 | $450K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$1.5M · 7 reports
- Medical research and clinical labs$210K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES10 reports
- Health & Human Services, Dept of (HHS)7 reports
- SENATE7 reports
- Centers For Medicare and Medicaid Services (CMS)6 reports
Firms it paid
| Firm | ||
|---|---|---|
| Ballard Partners | $1.7M | 10 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DANIEL MCFAUL | Legislative Director to U.S. Representative Joe Scarborough; Chief of Staff to U.S. Representatives Jeff Miller and Matt Gaetz | Q2 2026 |
| MICHAEL LAROSA | (Lobbying limited to Congress) EA, Congresswoman Bean; Assistant to DepDir, OPM; Comm Dir, ENRC, Senate; DPCC, Comm Dir, Speaker Pelosi; Biden Harris Transition Team, Press Sec. First Lady; SA to President Biden; Press Sec. First Lady | Q3 2025 |
| TOLA THOMPSON | Communications Director and Senior Legislative Assistant to U.S. Representative Carrie Meek (1993-2002); Chief of Staff to U.S. Representative Al Lawson (2017-2021) | Q3 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/16for Q2 | Ballard Partners | $450K |
| 04/19for Q1 | Ballard Partners | $500K |
| 01/20for Q4 2025 | Ballard Partners | $200K |
| 25/10/19for Q3 2025 | Ballard Partners | $80K |
| 25/07/18for Q2 2025 | Ballard Partners | $80K |
| 25/04/19for Q1 2025 | Ballard Partners | $80K |
| 25/04/18for Q1 2025 | Ballard Partners | $130K |
| 25/01/20for Q4 2024 | Ballard Partners | $80K |
| 24/10/20for Q3 2024 | Ballard Partners | $80K |
| 24/07/21for Q2 2024 | Ballard Partners | $80K |
| 24/04/21for Q1 2024 | Ballard Partners | $50K |
| 24/04/02for Q1 2024 | Ballard Partners | Under $5,000 |